Pulmonary Alveolar Microlithiasis

Symptoms

Common signs and symptoms of Pulmonary Alveolar Microlithiasis include:

Progressive shortness of breath during physical activity

Persistent dry cough that doesn't produce mucus

Chest tightness or feeling of pressure

Fatigue that worsens over time

Reduced exercise tolerance

Chest pain that may be sharp or aching

Crackling sounds in lungs when breathing deeply

Clubbing of fingertips in advanced cases

Blue-tinged lips or fingernails with exertion

Weight loss in later stages

When to see a doctor

If you experience severe or worsening symptoms, seek immediate medical attention. Always consult with a healthcare professional for proper diagnosis and treatment.

Causes & Risk Factors

Several factors can contribute to Pulmonary Alveolar Microlithiasis.

Pulmonary alveolar microlithiasis results from mutations in the SLC34A2 gene, which provides instructions for making a protein called sodium-phosphate cotransporter 2b.

Pulmonary alveolar microlithiasis results from mutations in the SLC34A2 gene, which provides instructions for making a protein called sodium-phosphate cotransporter 2b. This protein normally helps remove phosphate from the alveoli, keeping these air sacs clear and functional. When the gene doesn't work properly, phosphate accumulates and combines with calcium to form countless tiny stones throughout the lungs.

The disease follows an autosomal recessive pattern, meaning both parents must carry a copy of the mutated gene for their child to develop the condition.

The disease follows an autosomal recessive pattern, meaning both parents must carry a copy of the mutated gene for their child to develop the condition. Many carriers never know they have the gene mutation because they remain completely healthy. This explains why the disease can appear to skip generations or surprise families with no known history of lung problems.

Unlike other lung diseases, environmental factors like smoking, air pollution, or occupational exposures don't cause pulmonary alveolar microlithiasis.

Unlike other lung diseases, environmental factors like smoking, air pollution, or occupational exposures don't cause pulmonary alveolar microlithiasis. The condition develops purely from genetic factors, though external triggers might influence how quickly symptoms appear or progress. Research continues into why some people with the same genetic mutations develop symptoms earlier or more severely than others.

Risk Factors

Having two parents who carry the SLC34A2 gene mutation
Family history of unexplained lung disease
Consanguineous parents (related by blood)
Mediterranean, Middle Eastern, or Turkish ancestry
Japanese or Korean heritage
History of lung problems in siblings
Parents who are both carriers of the recessive gene

Diagnosis

How healthcare professionals diagnose Pulmonary Alveolar Microlithiasis:

1
Diagnosing pulmonary alveolar microlithiasis often begins when a routine chest X-ray reveals an unmistakable pattern doctors call a "sandstorm" appearance.
Diagnosing pulmonary alveolar microlithiasis often begins when a routine chest X-ray reveals an unmistakable pattern doctors call a "sandstorm" appearance. The lungs show countless tiny white spots scattered throughout both sides, creating a distinctive picture that's almost impossible to mistake for other conditions. Many people receive their diagnosis during routine medical exams, even before they notice any breathing problems.
2
Doctors typically order a high-resolution CT scan to confirm the diagnosis and assess the extent of calcium deposits.
Doctors typically order a high-resolution CT scan to confirm the diagnosis and assess the extent of calcium deposits. This detailed imaging shows the characteristic ground-glass appearance with tiny nodules throughout the lungs. Pulmonary function tests measure how well the lungs work, often revealing reduced oxygen transfer even when breathing feels relatively normal. Blood tests usually come back normal, which helps rule out other lung diseases.
3
Genetic testing can identify mutations in the SLC34A2 gene, providing definitive confirmation of the diagnosis.
Genetic testing can identify mutations in the SLC34A2 gene, providing definitive confirmation of the diagnosis. Some doctors may perform a lung biopsy, though the imaging findings are usually so characteristic that this invasive procedure isn't necessary. The combination of family history, distinctive imaging patterns, and genetic testing typically provides enough evidence for a confident diagnosis.

Complications

The primary complication of pulmonary alveolar microlithiasis is progressive respiratory failure as calcium deposits increasingly interfere with oxygen transfer.
This process typically unfolds over decades, giving people time to adapt and seek appropriate treatment.
Some individuals develop pulmonary hypertension - high blood pressure in the lung arteries - as the heart works harder to pump blood through damaged lung tissue.
Secondary complications can include recurrent lung infections, since the calcium deposits may interfere with the lungs' natural defense mechanisms.
Some people experience spontaneous pneumothorax, where air leaks into the chest cavity and collapses part of the lung.
In advanced cases, heart failure may develop as the right side of the heart struggles against increased pressure in the pulmonary circulation.
With proper medical management and monitoring, many of these complications can be treated effectively or prevented altogether.

Prevention

Since pulmonary alveolar microlithiasis results from inherited genetic mutations, traditional prevention strategies don't apply.
The condition develops regardless of lifestyle choices, environmental exposures, or preventive medical care.
However, genetic counseling can help families understand their risk and make informed decisions about having children.
Couples with a family history of the condition can undergo genetic testing to determine if they carry the SLC34A2 gene mutation.
If both partners are carriers, each pregnancy has a 25% chance of producing a child with the disease.
Prenatal genetic testing can detect the condition early in pregnancy, allowing families to prepare for specialized medical care or consider their options.
While the disease itself can't be prevented, early diagnosis through family screening allows for better monitoring and symptom management.
People with known genetic risk can undergo regular lung function tests and imaging to catch disease progression early.
This proactive approach helps doctors intervene with treatments like oxygen therapy or pulmonary rehabilitation before symptoms become severe.

Treatment Approaches

Currently, no specific treatment can stop or reverse the calcium deposits in pulmonary alveolar microlithiasis.

Currently, no specific treatment can stop or reverse the calcium deposits in pulmonary alveolar microlithiasis. Treatment focuses on managing symptoms and maintaining the best possible quality of life. Doctors may prescribe bronchodilators to help open airways, though these medications provide limited benefit since the problem lies in the air sacs rather than the breathing tubes.

Medication

Oxygen therapy becomes necessary as the disease progresses and the lungs struggle to transfer oxygen effectively.

Oxygen therapy becomes necessary as the disease progresses and the lungs struggle to transfer oxygen effectively. Many people start with supplemental oxygen during exercise or sleep, gradually needing it more throughout the day. Pulmonary rehabilitation programs can help maintain physical fitness and teach breathing techniques that maximize lung efficiency.

TherapyLifestyle

For people with end-stage disease, lung transplantation offers the only definitive treatment option.

For people with end-stage disease, lung transplantation offers the only definitive treatment option. The procedure can be highly successful since the underlying genetic condition doesn't affect the transplanted lungs. However, doctors carefully evaluate candidates based on overall health, age, and disease severity before recommending this major surgery.

Surgical

Researchers continue investigating potential treatments, including medications that might dissolve calcium deposits or prevent new ones from forming.

Researchers continue investigating potential treatments, including medications that might dissolve calcium deposits or prevent new ones from forming. Some studies explore whether certain diuretics or phosphate-binding medications could slow disease progression, though results remain preliminary. Regular monitoring helps doctors track disease advancement and adjust treatment plans as needed.

Medication

Living With Pulmonary Alveolar Microlithiasis

Living with pulmonary alveolar microlithiasis requires adapting to gradually changing lung function while maintaining an active, fulfilling life. Many people find that pacing activities and using energy conservation techniques help manage fatigue and shortness of breath. Regular exercise, as tolerated, helps maintain cardiovascular fitness and overall strength, though activities may need modification as the disease progresses.

Support from healthcare teams, including pulmonologists, respiratory therapists, and social workers, provides both medical expertise and emotional guidance.Support from healthcare teams, including pulmonologists, respiratory therapists, and social workers, provides both medical expertise and emotional guidance. Many people benefit from connecting with others who have rare diseases, even if not the same condition, since they share similar experiences of navigating complex medical care and uncertainty. Online support groups and rare disease organizations can provide valuable resources and community connections.

Planning ahead becomes increasingly important as the disease progresses.Planning ahead becomes increasingly important as the disease progresses. This might include: - Discussing treatment preferences and goals with healthcare providers - Exploring disability benefits and workplace accommodations - Considering home modifications for oxygen equipment - Learning about lung transplant evaluation processes - Maintaining strong relationships with family and friends who provide practical and emotional support - Staying up-to-date on research developments and potential new treatments

Latest Medical Developments

Latest medical developments are being researched.

Frequently Asked Questions

Is pulmonary alveolar microlithiasis contagious?

No, this is a genetic condition that cannot be spread from person to person through any form of contact. It develops only in people who inherit specific gene mutations from both parents.

Can I still exercise with this condition?

Yes, though you may need to modify activities as the disease progresses. Low-impact exercises like walking, swimming, or cycling are often well-tolerated. Your doctor can help design an appropriate exercise plan.

Will my children definitely have this disease?

Not necessarily. If your partner doesn't carry the gene mutation, your children won't develop the disease, though they may be carriers. Genetic counseling can help assess your specific risk.

How quickly does this condition progress?

The disease typically progresses very slowly over 20 to 30 years. Many people maintain relatively normal activities for decades before needing significant medical intervention.

Are there any dietary restrictions I should follow?

Currently, no specific diet has been proven to slow disease progression. However, maintaining good overall nutrition supports lung health and general well-being.

Can this condition be detected before symptoms appear?

Yes, genetic testing can identify the condition in family members before symptoms develop. Regular chest X-rays may also detect early calcium deposits.

What's the difference between this and other lung diseases?

Unlike conditions caused by smoking or environmental exposures, this is purely genetic. The characteristic sandstorm pattern on X-rays makes it quite distinct from other lung diseases.

Is lung transplant the only cure?

Currently, yes. Lung transplantation is the only treatment that can completely restore normal lung function, though it's typically reserved for advanced cases.

Can pregnancy affect this condition?

Pregnancy may temporarily worsen breathing symptoms due to increased oxygen demands, but it doesn't appear to accelerate long-term disease progression. Close monitoring is recommended.

Are there any new treatments being researched?

Researchers are investigating medications that might dissolve calcium deposits or prevent new ones from forming, though these treatments are still experimental and not yet available.

Update History

May 7, 2026v1.0.0

Published by DiseaseDirectory